Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea flag South Korea · Delayed Price · Currency is KRW
121,900
+3,000 (2.52%)
At close: Jul 16, 2026

Daewoong Pharmaceutical Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, Daewoong Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ₩207,778. The average 1-year stock price forecast is 70.45% higher than the current stock price, while the lowest is ₩200,000 (+64.07%) and the highest is ₩220,000 (+80.48%).

Price Target: ₩207,778 (+70.45%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price₩200,000₩207,778₩210,000₩220,000
Change+64.07%+70.45%+72.27%+80.48%

Analyst Ratings

The average analyst rating for Daewoong Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy554544
Buy555655
Hold000000
Sell000000
Strong Sell000000
Total101091199

Financial Forecast

Revenue This Year
1.66T
from 1.57T
Increased by 5.82%
Revenue Next Year
1.77T
from 1.66T
Increased by 6.54%
EPS This Year
17.32K
from 14.45K
Increased by 19.88%
EPS Next Year
17.59K
from 17.32K
Increased by 1.56%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.15T1.28T1.38T1.42T1.57T1.66T
Revenue Growth
9.24%11.03%7.44%3.44%10.42%5.82%
Gross Profit
543.75B638.09B687.11B734.17B822.53B846.51B
Gross Margin
47.16%49.85%49.96%51.60%52.36%50.93%
Operating Income
88.73B95.80B121.12B145.24B195.51B218.28B
Net Income
24.51B42.24B121.74B24.73B195.86B184.88B
EPS
----14,449.0017,321.67
EPS Growth
----285.20%19.88%
Forward PE
41.3522.7714.7714.3911.767.04
Dividend / Share
----600.00600.00
Free Cash Flow
44.98B-44.86B-18.39B-174.86B-98.63B159.50B
No. Analysts
-----4
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.

Revenue Forecast

Revenue202620272028
High1.7T
Avg1.7T
Low1.6T

Revenue Growth

Revenue Growth202620272028
High
7.8%
Avg
5.8%
Low
1.2%

EPS Forecast

EPS202620272028
High21,951.00
Avg17,321.67
Low14,951.00

EPS Growth

EPS Growth202620272028
High
51.9%
Avg
19.9%
Low
3.5%